Postdoc

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

E-pub date: 30 Nov 2015


A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

E-pub date: 31 Oct 2015


A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy.

E-pub date: 31 Aug 2015


A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo.

E-pub date: 31 Oct 2013


The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.

E-pub date: 31 May 2013


Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes.

E-pub date: 01 Jun 2012


Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling network.

E-pub date: 01 Jul 2011


The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis.

E-pub date: 31 Jan 2011


Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?

E-pub date: 31 Dec 2010


p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.

E-pub date: 28 Feb 2010


Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes.

E-pub date: 30 Apr 2009


How do microRNAs regulate gene expression?

E-pub date: 01 Dec 2008


The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene.

E-pub date: 30 Jun 2008


Show all